SK inks $795m Biohaven epilepsy deal, entering potassium channel opener race Pharmaceutical Technology 2d
African bundibugyo ebolavirus vaccine candidate to be advanced to clinical trials Biotech, B3C newswire 3d Biotech
Moderna and Merck’s Personalized mRNA Cancer Vaccine Succeeds in Landmark Phase 3 Melanoma Trial The Red Ferret Journal 7d Moderna Merck and Co Pharma
Iovance Biotherapeutics stock is trending Friday: What's going on? Benzinga 15:15 Fri, 21 Aug Article paywall
STAT Plus: A Novartis drug cut inflammation. Can it improve heart outcomes? STAT 14h Novartis Science
Bioxcel files for chapter 11, Teva bids on Igalmi for up to $125M BioWorld 1d Teva Biotech Article paywall
